Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
Balaian, Larisa
Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways. [electronic resource] - Experimental hematology Feb 2005 - 199-211 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0301-472X
10.1016/j.exphem.2004.11.004 doi
Antibodies, Monoclonal--pharmacology
Antigens, CD--immunology
Antigens, Differentiation, Myelomonocytic--immunology
Cell Line, Tumor
Cell Survival--drug effects
Cytarabine--toxicity
Humans
Idarubicin--toxicity
Leukemia, Myeloid, Acute
Sialic Acid Binding Ig-like Lectin 3
Signal Transduction--drug effects
Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways. [electronic resource] - Experimental hematology Feb 2005 - 199-211 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0301-472X
10.1016/j.exphem.2004.11.004 doi
Antibodies, Monoclonal--pharmacology
Antigens, CD--immunology
Antigens, Differentiation, Myelomonocytic--immunology
Cell Line, Tumor
Cell Survival--drug effects
Cytarabine--toxicity
Humans
Idarubicin--toxicity
Leukemia, Myeloid, Acute
Sialic Acid Binding Ig-like Lectin 3
Signal Transduction--drug effects